Article
Role of genomics in identifying new targets for cancer therapy.
Oncology (Williston Park, N.Y.) - 1 May 2002
Anzick Sarah L, Trent Jeffrey M
Abstract excerpt
The detailed map of the human genome can potentially transform future cancer therapy by merging genomics with pharmacology, thereby identifying which patients will benefit from specific therapeutic agents. Single-nucleotide polymorphisms (SNPs) provide a valuable tool for this pharmacogenetic approach to cancer therapy. The discovery of SNPs as disease markers may facilitate identification of populations at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
